Hranipur 15

Hazard statements (CLP)

H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Harmful if inhaled. Causes skin irritation. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. Suspected of causing cancer. May cause respiratory irritation. May cause damage to the respiratory system through prolonged or repeated exposure. Route of exposure: Inhalation

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

Diphenylmethanediisocyanate, isomers and homologues

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to the respiratory system through prolonged or repeated exposure. Route of exposure: Inhalation.

Precautionary statements

P261 - Avoid breathing dust, fume, gas, mist, vapours, spray. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call a doctor if you feel unwell.

Supplemental label elements

EUH204 - Contains isocyanates. May produce an allergic reaction.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

Other hazards which do not result in classification

Persons suffering from asthma or eczema and persons who have chronic lung diseases, skin or respiratory allergies to isocyanates should not work with the material. Symptoms of excessive exposure to the respiratory tract to the product may persist for several hours. Dust, fumes and aerosols form a fundamental threat to the respiratory tract. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (inhalation:dust,mist) Category 4 H332 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Respiratory sensitisation, Category 1 H334 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 2 H351 Specific target organ toxicity – Single exposure, Category 3, H335 Respiratory tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Harmful if inhaled. Causes skin irritation. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. Suspected of causing cancer. May cause respiratory irritation. May cause damage to the respiratory system through prolonged or repeated exposure. Route of exposure: Inhalation.